Our study confirms the overexpression of SULF1 and SULF2 in various cancers, which is commonly associated with poor survival outcomes; the 6-O-endosulfatases emerge as interesting targets for cancer monitoring and therapeutic intervention. Here, SULF2 is linked to cancer.